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My two children were diagnosed with Alström Syndrome
when aged 15 and 18 after a long battle to get their multi-
ple medical conditions recognised as a syndrome. After
diagnosis it was apparent that there were no experts in the
condition in the UK and little information. To address this
I founded the charity AS UK to bring together the 7
known cases with the doctors who had worked with my
children. Their experience of the disease increased over-
night primarily through talking with parents and patients
who were the only experts in the disease. The first meet-
ings were held in a hotel, later we moved to Torbay hospi-
tal using equipment at the weekend when no one else was
using it. The ethos of listening to patients and parents as
experts was fundamental to the development of the clinics.
In 2006 we were successful in getting the NHS National
Specialised Commissioning Group to recognise the impor-
tance of the clinics and they now fund children’s clinics at
the Birmingham Children’s Hospital and adult’s clinics at
the Queen Elizabeth Hospital Birmingham. AS UK was
the first charity to be funded as an equal partner with the
two hospitals. Today 55 patients are seen at the two clinics
and expertise continues to grow. In 2009 AS UK was suc-
cessful in gaining Big Lottery Medical and Scientific Fund-
ing and research has started. A database has been set up
and tissue bank begun. In 2010 AS UK became a partner
in an EU wide project with two other rare conditions
EURO-WABB (Wolfram, Alström and Bardet Biedl) The
overall aim is for this register to be a key instrument to
increase knowledge on these rare diseases, improve the
lives of affected people through better management, and
to develop clinical research. In 2011 AS UK started an
Asian mentoring scheme in response to the high number
of Asian patients in families whose culture practice con-
sanguinity. From the initial 3 Asian patients known to us
we now know of 24 patients most are related. This is an
area we are developing further. From small beginnings this
patient led initiative has shown how an ultra-rare condi-
tion can go from obscurity to gaining NHS specialised
clinical services, National and European research projects,
medical handbooks, patient information, clinical guidelines
and improved quality of life for patients.
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